文献速递冠心病

导管室诊断心绞痛与非阻塞性冠状动脉疾病

Diagnosis of patients with angina and non-obstructive coronary disease in the catheter laboratory.
PubMed 文献 · Heart · 2019-07-31

约40%的造影患者冠状动脉正常或为非阻塞性冠状动脉疾病(NOCAD),其中半数存在冠状动脉微血管功能障碍(CMD),与主要不良心血管事件风险升高相关。本文提出一种结构化算法,利用压力导丝和血流测量在单次造影过程中识别NOCAD的不同疾病表型并指导治疗。

要点

  • 约40%造影患者为NOCAD,其中半数存在CMD,后者与MACE风险升高相关。
  • 血流测量可在造影过程中对NOCAD进行分类,部分压力导丝已整合该功能。
  • 结构化算法有助于识别NOCAD表型并指导个体化治疗。

核心结论

  • 在导管室对NOCAD患者进行血流评估可识别CMD等表型,为个体化治疗提供靶点。

研究设计与样本

  • 综述性文章,提出针对导管室中NOCAD患者的结构化诊断算法。

主要发现

  • 约40%的造影患者为正常冠状动脉或NOCAD。
  • NOCAD患者中半数存在CMD,且CMD与主要不良心血管事件风险升高相关。

临床怎么用

  • 可利用压力导丝测量血流,在单次造影过程中对NOCAD进行分类。
  • 按照结构化算法识别特定疾病表型并链接相应治疗。

局限性

  • 所提算法及个体化治疗策略需未来试验验证其对临床结局和卫生经济学效益的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Around 40% of all patients undergoing angiography are found to have normal coronary arteries or non-obstructive coronary artery disease (NOCAD). Despite the high prevalence, this is a group who rarely receive a definitive diagnosis, are frequently labelled and managed inappropriately and by and large, continue to remain symptomatic. Half of this group will have coronary microvascular dysfunction (CMD), associated with a higher rate of major adverse cardiovascular events; identifying CMD represents a therapeutic target of unmet need. As the pressure wire has revolutionised our ability to interrogate epicardial coronary disease during the time of angiography, measuring flow can similarly classify NOCAD during a single procedure. Assessment of flow is a function that is already integral to some pressure wires and furthermore, the familiarity and usage of the combined Doppler and pressure wire is rapidly increasing-these are techniques that readily lend themselves to the skillset of a practising interventional cardiologist. We present a structured algorithm designed for cardiologists who frequently encounter NOCAD in the catheter laboratory, identifying specific disease phenotypes within this heterogeneous population with linked therapy. This review paper clearly explains the rationale for this algorithm and outlines its applicability to routine clinical practice and also, the importance of phenotyping for future research. Ultimately, personalised therapy could improve outcomes for both patients and healthcare providers; while these approaches in turn will need robust evaluation to ensure that they improve both clinical outcomes and health economic benefits, this proposal will provide a framework for future trials and evaluations.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Rahman H, Corcoran D, Aetesam-Ur-Rahman M, et al. Diagnosis of patients with angina and non-obstructive coronary disease in the catheter laboratory. Heart. 2019. PMID: 31366574. doi:10.1136/heartjnl-2019-315042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。